Update: GFI Board Rejects BGC Offer
BGC insists its offer still stands.
The latest salvo in the long-running battle between GFI ─ which initially announced that it would be acquired by the Chicago Mercantile Exchange (CME) Group in July ─ and BGC means that the offer is open to shareholders without the support of the company's management. BGC had previously entered into negotiations over its offer, which values the company at $5.25 per share, but turned it hostile after it accused GFI's board of not negotiating in good faith. GFI, for its part, describes BGC's advances as "unsolicited", and says that the board still supports the original deal with CME Group.
Recommendations from the committee for rejecting the offer centered on the likelihood of the deal being consummated, which it said was much higher with the original CME deal than the offer presented by BGC, which currently owns 13.5 percent of the firm.
"The board carefully considered the unanimous determination and recommendation of the special committee of the board to reject the offer after consultation with its independent financial advisor and outside legal counsel," says GFI, in a statement posted to its investor relations website. "The special committee and the board determined that the offer is highly conditional and is not in the best interests of GFI or its stockholders. Accordingly, the board recommends that GFI stockholders reject the offer and not tender their shares into the offer."
GFI has published the recommendations of the special committee and its reasoning in a Schedule 14D-9 filing with the US Securities and Exchange Commission. There was no immediate public comment from either BGC Partners or the CME Group. However, in an interview with Reuters published yesterday, CME chairman Terry Duffy expressed optimism that Trayport and Fenics, the technology products owned by GFI at the heart of the tussle, would be available no matter the outcome of the spat.
Update (November 6): BGC Partners has released a statement saying that its offer for GFI still stands up to the closing date of November 19, by which shareholders must respond. The firm reinforced its belief that the higher price value placed on the CME offer of $4.55 per share constitutes a superior offer, but said that it would amend aspects of its proposal to counter the objections put forward by GFI's special committee.
"We are confident that GFI's outside shareholders will view BGC's fully financed, $5.25 per share all-cash tender offer as superior to the $4.55 per share all-stock transaction with CME," says Howard Lutnick, chairman and CEO of BGC. "We remain committed to completing our tender, which provides a higher all-cash price, and which has closing conditions offering BGC protections substantially similar to the protections offered to CME by GFI."
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
Man Group CTO eyes ‘significant impact’ for genAI across the fund
Man Group’s Gary Collier discussed the potential merits of and use cases for generative AI across the business at an event in London hosted by Bloomberg.
BNY Mellon deploys Nvidia DGX SuperPOD, identifies hundreds of AI use cases
BNY Mellon says it is the first bank to deploy Nvidia’s AI datacenter infrastructure, as it joins an increasing number of Wall Street firms that are embracing AI technologies.
This Week: Linedata acquires DreamQuark, Tradeweb, Rimes, Genesis, and more
A summary of some of the latest financial technology news.
Systematic tools gain favor in fixed income
Automation is enabling systematic strategies in fixed income that were previously reserved for equities trading. The tech gap between the two may be closing, but differences remain.
Euronext microwave link aims to cut HFT advantage in Europe
Exchange plans to level playing field between prop firms and banks in cash equities with cutting edge tech.
Why recent failures are a catalyst for DLT’s success
Deutsche Bank’s Mathew Kathayanat and Jie Yi Lee argue that DLT's high-profile failures don't mean the technology is dead. Now that the hype has died down, the path is cleared for more measured decisions about DLT’s applications.
‘Very careful thought’: T+1 will introduce costs, complexities for ETF traders
When the US moves to T+1 at the end of May 2024, firms trading ETFs will need to automate their workflows as much as possible to avoid "settlement misalignment" and additional costs.
Waters Wrap: Examining the changing EMS landscape
After LSEG’s decision to sunset Redi, Anthony examines what might lie ahead for the EMS space.
Most read
- Sell-Side Technology Awards 2024: All the winners
- Sell-Side Technology Awards 2024: Best sell-side front-office platform—Bloomberg
- Systematic tools gain favor in fixed income